IGC China 2019 3rd China International Forum on Immunization and Gene Therapy (Beijing)

IGC China 2019 (Third China International Forum on Immunization and Gene Therapy) will be held from August 30 to 31, 2019. It is co-sponsored by Shanghai Business Map Information Consulting Co., Ltd. and China Bioengineering Society.

From the three perspectives of drug discovery, medical transformation and industrialization, cellular immunotherapy and molecular immunotherapy-gene therapy, the conference will analyze the policy and regulatory trend of immunization and gene therapy, and discuss cellular immunotherapy, large and small molecular immunotherapy, therapeutic cancer vaccine and oncolytic disease at home and abroad. Advanced breakthroughs in new research, new technologies and new products of toxic immunogene therapy will promote in-depth exchanges and cooperation between industry, university, research and medicine, and accelerate the industrial transformation of immunization and gene therapy.

Highlights of this session:

1. Registration and technical standard analysis of cell therapy;

2. Leading experience in quality control production of immunocyte products with cost reduction and efficiency enhancement.

3. The latest technology and research and development of cellular immunotherapy: breakthroughs in immunocytotherapy such as neoantigen, TIL cells, macrophages, U-CAR, etc.

4. To explore the innovative development of the next generation of immunotherapy drugs from the perspective of tumor microenvironment and immunological mechanism.

5. Advances and breakthroughs in pharmaceuticals and pharmacodynamics of hot technical categories of immunocombinatorial therapy such as therapeutic cancer vaccines and oncolytic drugs.